Researchers Reveal How Female Fertility Declines Earlier Than Expected

A recent study has identified that female fertility begins to decline earlier than commonly perceived, specifically after the age of 32. This research, conducted by scientists at Jilin University in China, highlights critical implications for women’s reproductive health as many are delaying motherhood into their thirties and forties. The findings point towards a potential avenue for future treatments aimed at extending women’s fertility.

The Centers for Disease Control and Prevention (CDC) reports a significant demographic shift: in 1970, the average age of first-time mothers in the United States was 21.4 years, while by 2023, it had risen to 27.5 years. As women increasingly postpone family planning, they face heightened risks of fertility challenges. Although options like egg freezing and in vitro fertilization (IVF) exist, understanding the underlying causes of fertility decline remains crucial.

In their analysis, the researchers examined data from over 15,000 embryos produced through IVF. They discovered that among women aged 20 to 32, about 20% of eggs exhibited chromosomal errors. This figure escalates significantly after age 32, with more than half of eggs from women in their mid-thirties displaying chromosomal abnormalities, a major factor contributing to miscarriage, infertility, and conditions such as Down syndrome.

As age increases, the risk of chromosomal issues continues to climb. The study attributes this decline partly to a ring-shaped protein known as cohesin, which plays a critical role in maintaining chromosomal integrity during egg development. Unfortunately, levels of cohesin decrease as women age. Eggs from women over 40 were found to contain up to one-third less cohesin than those from women in their twenties.

Animal studies corroborate these findings. In mice, by 17 months of age—equivalent to a woman’s late thirties—over 95% of cohesin was depleted. The loss of cohesin leads to premature chromosome separation and improper distribution, resulting in eggs with incorrect chromosomal counts. Moreover, cohesin is essential for DNA repair; diminished levels can lead to accumulated DNA damage, further increasing the risk of cancer and developmental disorders in offspring.

The reasons for the decline in cohesin levels with age are still under investigation. Researchers have identified several contributing factors, including the gradual loss of protective proteins that typically safeguard cohesin and the oxidative stress that accumulates in the body over time. Additionally, cellular signals that ensure cohesin stability weaken as eggs mature.

Two specific pathways are highlighted in the study: the mTOR pathway, which regulates cell growth and cohesin attachment, and the ATM pathway, which coordinates DNA repair. Preliminary studies suggest that modifying the mTOR pathway in yeast could potentially enhance cohesin levels, although the application of this approach in humans remains uncertain. The ATM pathway becomes less efficient in older eggs, accelerating cohesin loss and compounding fertility issues.

The researchers recommend further investigations into how these pathways influence cohesin levels. Understanding these mechanisms could pave the way for innovative strategies to preserve egg quality as women age, ultimately providing more options for those facing fertility challenges.

This study underscores the importance of early awareness and understanding of female fertility, particularly as societal trends continue to push family planning into later years. The implications of this research could significantly impact both reproductive health treatments and personal choices regarding motherhood.